Follow Feed 커뮤니티에서 거래자 및 투자자와 연결하세요.
포괄적인 옵션 데이터를 탐색하고 옵션 흐름으로 고급 필터를 사용하세요.
터미널 모니터로 주식 및 자산 관심 목록을 구성하고 모니터링하세요.
DOR BioPharma, Inc. (AMEX:DOR) ("DOR", or the "Company") announced today the first successful evaluation in animal tests of a nasal, bivalent...
DOR BioPharma, Inc. ("DOR" or the "Company") (AMEX:DOR) announced that it has entered into definitive agreements for the sale of securities in a...
DOR BioPharma, Inc. (AMEX:DOR) ("DOR" or the "Company") announced today its financial results for 2005. ? Revenues for 2005 were $3,075,736...
DOR BioPharma, Inc. (AMEX:DOR) ("DOR", or the "Company") announced today that it is focusing its resources on the preparation of New Drug...
DOR BioPharma, Inc. (AMEX:DOR) ("DOR", or the "Company") today announced results of a Phase I clinical trial of RiVax(TM), a recombinant vaccine...
DOR BioPharma, Inc. (AMEX:DOR) ("DOR", or the "Company") today announced that it has successfully completed the second development milestone for...
DOR BioPharma, Inc. (AMEX:DOR) ("DOR", or the "Company") announced today that as part of its process to submit a New Drug Application ("NDA") for...
DOR BioPharma, Inc. ("DOR" or the "Company") (AMEX:DOR), today announced that it has entered into a common stock purchase agreement with Fusion...
DOR BioPharma, Inc. (AMEX:DOR) ("DOR" or the "Company"), announced today that following written communications and meetings with the FDA and with...
DOR BioPharma Inc. (AMEX: DOR) ("DOR" or the "company") announced today its financial results for the third quarter ended Sept. 30, 2005. The...
DOR BioPharma, Inc. (AMEX: DOR) ("DOR" or the "Company"), announced today that Evan Myrianthopoulos, Chief Financial Officer of DOR, will be...
DOR BioPharma, Inc. (AMEX: DOR) ("DOR" or the "Company"), announced today that it has signed a binding letter of intent to acquire Gastrotech...
DOR BioPharma, Inc. (AMEX: DOR) ("DOR" or the "Company"), announced today that it has received notice from the American Stock Exchange (the...
DOR BioPharma, Inc. (AMEX:DOR) ("DOR" or the "Company"), today provided a general update on various corporate matters. ? orBec(R) IND Transferred...
EAST RUTHERFORD, N.J. and MIAMI, Sept. 15 /PRNewswire-FirstCall/ -- Cambrex Corporation (NYSE:CBM) and DOR BioPharma, Inc. (AMEX:DOR) are...
귀하가 조회한 주식이 이 박스에 나타나며 쉽게 최근 시세로 돌아갈 수 있습니다.
도움 및 지원받기: kr-support@advfn.com
ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관
광고 없는 경험을 위해 가입하세요
지금 사용해 보세요
광고 유지